Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100851452 | 10085145 | 2 | F | 201112 | 20140414 | 20140409 | 20150331 | PER | SP07525 | SALIX | 71.00 | YR | F | N | 122.00000 | LBS | 20150316 | N | LW | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100851452 | 10085145 | 1 | PS | OSMOPREP | SODIUM PHOSPHATE, DIBASIC, ANHYDROUSSODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 1 | ORAL | U | D | 21892 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100851452 | 10085145 | 1 | Bowel preparation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100851452 | 10085145 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100851452 | 10085145 | Acute kidney injury | |
| 100851452 | 10085145 | Nephropathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100851452 | 10085145 | 1 | 20111220 | 0 |